<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000512985">
  <TermName>PF-3512676</TermName>
  <TermDefinition>
    <DefinitionText>A substance that is being studied in the treatment of some types of cancer. It belongs to the family of drugs called biological response modifiers. Also called CpG 7909 and ProMune.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <SpanishTermName>PF-3512676</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Sustancia en estudio para el tratamiento de algunos tipos de cáncer. Es un tipo de modificador de la respuesta biológica. También se llama CpG 7909 y ProMune.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
  <DateFirstPublished>2006-10-14</DateFirstPublished>
  <DateLastModified>2006-10-12</DateLastModified>
</GlossaryTerm>
